Michael Golembiewski - Aug 31, 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Stock symbol
SEEL
Transactions as of
Aug 31, 2023
Transactions value $
$7,725
Form type
4
Date filed
9/1/2023, 04:15 PM
Previous filing
Mar 31, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Award $7.73K +12.5K +13.74% $0.62 103K Aug 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).